# Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes

> **NCT01219400** · PHASE4 · COMPLETED · sponsor: **Lund University** · enrollment: 28 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Vildagliptin

## Key facts

- **NCT ID:** NCT01219400
- **Lead sponsor:** Lund University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01219400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01219400, "Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01219400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*